Phase 3, randomized, double-blind, placebo-controlled study of pembrolizumab plus chemotherapy in patients with HR+/HER2-locally recurrent inoperable or metastatic breast cancer (mBC): KEYNOTE-B49

Schmid P., Sohn J. H., Jerez Gilarranz Y., Gonzalez-Cortijo L., Sonnenblick A., Sabanathan D., ...Daha Fazla

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, cilt.18, ss.233-234, 2022 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 18
  • Basım Tarihi: 2022
  • Dergi Adı: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.233-234
  • Hacettepe Üniversitesi Adresli: Evet